HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.

Abstract
The immunoreactivity of EchiTAb-Plus-ICP, an antivenom developed for the treatment of snakebite envenoming in sub-Saharan Africa, to venoms of seven Echis and Bitis species, was assessed by "antivenomics." This proteomic approach is based on the ability of an antivenom to immunodeplete homologous or heterologous venom proteins. Our results show an extensive cross-reactivity of this antivenom against all Echis and Bitis venoms studied, as revealed by the complete immunodepletion of the majority of venom components, including metalloproteinases, serine proteinases, C-type lectin-like proteins, some phospholipases A(2) and L-amino acid oxidase. However, some phospholipases A(2), disintegrins and proteinase inhibitors were immunodepleted to only a partial extent. These results support the hypothesis that immunizing horses with a mixture of the venoms of Echis ocellatus, Bitis arietans, and Naja nigricollis generates antibodies capable of recognizing the majority of components of medically-relevant homologous and heterologous viperid venoms of the genera Bitis and Echis from sub-Saharan Africa.
AuthorsJuan J Calvete, Pedro Cid, Libia Sanz, Alvaro Segura, Mauren Villalta, María Herrera, Guillermo León, Robert Harrison, Nandul Durfa, Abdusalami Nasidi, R David G Theakston, David A Warrell, José María Gutiérrez
JournalThe American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 82 Issue 6 Pg. 1194-201 (Jun 2010) ISSN: 1476-1645 [Electronic] United States
PMID20519622 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antivenins
  • Viper Venoms
Topics
  • Africa South of the Sahara
  • Animals
  • Antivenins (immunology)
  • Humans
  • Immunoprecipitation
  • Snake Bites (drug therapy)
  • Viper Venoms (immunology)
  • Viperidae (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: